Veon (VEON) Cash & Equivalents (2009 - 2025)

Veon's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.7 billion for Q4 2025.

• Quarterly Cash & Equivalents rose 2.55% year-over-year to $1.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 2.55% YoY) and the FY2025 annual result came in at $1.7 billion, up 2.55% from the prior year.
• Cash & Equivalents was $1.7 billion for Q4 2025 at Veon, up from $1.3 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.5 billion in Q2 2023 and bottomed at $2.0 million in Q3 2024.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 88.89% — and 2024, when it surged 42125.0%.
• Veon's Cash & Equivalents stood at $54.0 million in 2021, then slumped by 88.89% to $6.0 million in 2022, then slumped by 33.33% to $4.0 million in 2023, then jumped by 42125.0% to $1.7 billion in 2024, then grew by 2.55% to $1.7 billion in 2025.
• Business Quant data shows VEON's Cash & Equivalents at $1.7 billion in Q4 2025, $1.3 billion in Q2 2025, and $1.7 billion in Q4 2024.